:

FIREWORKS AI TARGETS $15B VALUATION IN NEW FUNDING ROUND

AI DESK1 MIN READ
WED, MAY 27, 2026

■ AI-SUMMARIZED FROM 3 SOURCES ▸ TIMELINE

Fireworks AI, a platform for running AI models, is negotiating a funding round that would value the startup at $15 billion, up from $4 billion in October 2025.

The startup, which provides infrastructure for companies to deploy and operate artificial intelligence models, has attracted significant investor interest in recent months. The proposed valuation represents a near-quadrupling of the company's worth in just a few months. Fireworks AI competes in the growing market of AI infrastructure providers, alongside companies like Together AI and modal Labs. The funding round would position the startup among the most valuable AI infrastructure companies. The timing reflects broader investor appetite for AI infrastructure tools as enterprises accelerate AI adoption. Companies increasingly seek alternatives to major cloud providers for running custom AI models, driving demand for specialized platforms. The specific funding amount and lead investors have not been disclosed. The talks are ongoing and valuations can change during negotiations.

■ SOURCES

TechmemeTechmemeTechmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Retro, a friend-focused photo-sharing app founded by former Instagram employees, has secured $21 million in Series A funding. The capital injection signals investor confidence in the social app's differentiated approach to photo sharing.

3H AGOIndustry Desk

Sweden has built one of Europe's most vibrant startup ecosystems, drawing attention from investors and entrepreneurs across the continent. Cherry Ventures general partner Sophia Bendz breaks down the factors driving the Nordic nation's tech boom.

3H AGOIndustry Desk

Metriport secured $26M in Series A and seed funding led by Matrix GP, bringing its total funding to $28.4M. The startup provides tools that enable doctors to retrieve and manage patient data.

6H AGOAI Desk

Faro, an AI platform for clinical trial optimization, closed a $37.3 million Series B round co-led by Merck Global Health Innovation Fund and S32. The funding will support development of data models and AI tools designed to streamline trial processes.

6H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.